US Patent Issued to AMRYT PHARMACEUTICALS on Nov. 18 for "Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patients" (Irish, Swiss Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,172, issued on Nov. 18, was assigned to AMRYT PHARMACEUTICALS INC. (Boston).

"Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patients" was invented by Ruth Nallen (Dublin), Tracy Cunningham (Dublin) and Mark Sumeray (Zug, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating hyperlipidemia or hypercholesterolemia in pediatric patients with lomitapide or a pharmaceutically acceptable salt thereof."

The patent was filed on Oct. 18, 2023, under Application No. 18/489,542.

*For further information, including images, charts and tables, please visit: http://patf...